epocrates logo
epocrates logo
epocrates logo
  • 0

Journal Article Synopsis

JAMA Neurol

Is seizure prophylaxis warranted after mild to moderate TBI?

May 7, 2024

card-image

Among patients with mild to moderate traumatic brain injury (TBI), seizure prophylaxis was associated with a small, but significant, reduced risk for early posttraumatic seizures (PTS). the small absolute risk reduction should be weighed against the risks of prescribing antiseizure medications.

  • For this systematic review and meta-analysis, investigators reviewed literature for observational studies of adults presenting to trauma centers in high-income countries with mild and moderate TBI. They compared rates of early PTS among patients with seizure prophylaxis vs. those without seizure prophylaxis.
  • A total of 64 full articles were reviewed after screening; 8 studies (including 5,637 patients) were included for the mild and moderate TBI analysis, and 5 studies (including 3,803 patients) were included for the mild TBI analysis. The overall rate of early posttraumatic seizures (PTS) was low, ranging from 0% to 4%.
  • The absolute risk reduction of seizure prophylaxis for early PTS in mild to moderate TBI (Glasgow Coma Scale [GCS], 9-15) was 0.6% (95% confidence interval [CI], 0.1%-1.2%; P = 0.02). The absolute risk reduction for mild TBI alone was similar at 0.6% (95% CI, 0.01%-1.2%; P = 0.04). The number needed to treat to prevent one seizure was 167.

Source:

Pease M, et al. (2024, April 8). JAMA Neurol. Early Seizure Prophylaxis in Mild and Moderate Traumatic Brain Injury: A Systematic Review and Meta-Analysis. https://pubmed.ncbi.nlm.nih.gov/38587858/

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus
Clinical FAQ icon

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information